Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
HNI $485 million acquisition of Kimball International
We are advising HNI on the transaction
Atairos acquisition of LifeLabs Learning
We are advising Atairos on the transaction
Fidelity National Information Services $2 billion 364-day revolver
We advised the lender parties on the facility
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction
Mitsubishi HC Finance America $500 million guaranteed notes offering
We advised Mitsubishi HC Finance America and Mitsubishi HC Capital on the guaranteed senior notes offering
Ankura Consulting Group acquisition of Chartwell Compliance
We advised Ankura Consulting Group on the transaction
Lavoro $1.2 billion combination with TPB Acquisition Corp. I
We advised Lavoro on the transaction with the SPAC
Assurant $175 million senior notes offering
We advised Assurant on the senior notes offering
Mizuho Financial Group $2.6 billion senior notes offering
The senior callable fixed-to-fixed reset rate notes are due 2029, 2031 and 2034
K&N Engineering recapitalization
We advised K&N in connection with its recapitalization